医薬品開発業務受託機関（CRO）市場は、2022年から2027年の間に524億6,000万米ドル成長すると予測されており、予測期間中にCAGRは11.75％で加速します。医薬品開発業務受託機関（CRO）市場に関するレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題に加えて、約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、バイオ医薬品産業の成長、慢性疾患の有病率の増加、ベンダーの活動の増加によって牽引されています。
この調査では、臨床試験数の増加が今後数年間の医薬品開発業務受託機関（CRO）市場成長を牽引する主要因の1つであると特定しています。また、ワクチン製造の増加、CROサービスの利用によるアウトソーシングとコスト削減の拡大は、同市場の大きな需要につながります。
堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。また、医薬品開発業務受託機関（CRO）市場分析レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global contract research organization (CRO) market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global contract research organization (cro) market 2017 - 2021 ($ billion)
4.2 Application Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2022-2027 (%)
Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Clinical research - Market size and forecast 2022-2027
Exhibit 34: Chart on Clinical research - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Clinical research - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Clinical research - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Clinical research - Year-over-year growth 2022-2027 (%)
6.4 Early phase development - Market size and forecast 2022-2027
Exhibit 38: Chart on Early phase development - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Early phase development - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Early phase development - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Early phase development - Year-over-year growth 2022-2027 (%)
6.5 Laboratory - Market size and forecast 2022-2027
Exhibit 42: Chart on Laboratory - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on Laboratory - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on Laboratory - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Laboratory - Year-over-year growth 2022-2027 (%)
6.6 Regulatory consulting - Market size and forecast 2022-2027
Exhibit 46: Chart on Regulatory consulting - Market size and forecast 2022-2027 ($ billion)
Exhibit 47: Data Table on Regulatory consulting - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Chart on Regulatory consulting - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Regulatory consulting - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Application
Exhibit 50: Market opportunity by Application ($ billion)
Exhibit 51: Data Table on Market opportunity by Application ($ billion)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 52: Chart on End-user - Market share 2022-2027 (%)
Exhibit 53: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 54: Chart on Comparison by End-user
Exhibit 55: Data Table on Comparison by End-user
7.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027
Exhibit 56: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ billion)
Exhibit 58: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%)
7.4 Medical device companies - Market size and forecast 2022-2027
Exhibit 60: Chart on Medical device companies - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Data Table on Medical device companies - Market size and forecast 2022-2027 ($ billion)
Exhibit 62: Chart on Medical device companies - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Medical device companies - Year-over-year growth 2022-2027 (%)
7.5 Academic institutes - Market size and forecast 2022-2027
Exhibit 64: Chart on Academic institutes - Market size and forecast 2022-2027 ($ billion)
Exhibit 65: Data Table on Academic institutes - Market size and forecast 2022-2027 ($ billion)
Exhibit 66: Chart on Academic institutes - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Academic institutes - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by End-user
Exhibit 68: Market opportunity by End-user ($ billion)
Exhibit 69: Data Table on Market opportunity by End-user ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 107: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 108: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 109: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 BioAgile Therapeutics Pvt. Ltd
Exhibit 119: BioAgile Therapeutics Pvt. Ltd - Overview
Exhibit 120: BioAgile Therapeutics Pvt. Ltd - Product / Service
Exhibit 121: BioAgile Therapeutics Pvt. Ltd - Key offerings
12.4 Charles River Laboratories International Inc.
Exhibit 122: Charles River Laboratories International Inc. - Overview
Exhibit 123: Charles River Laboratories International Inc. - Business segments
Exhibit 124: Charles River Laboratories International Inc. - Key news
Exhibit 125: Charles River Laboratories International Inc. - Key offerings
Exhibit 126: Charles River Laboratories International Inc. - Segment focus
12.5 CTI Clinical Trial and Consulting Inc.
Exhibit 127: CTI Clinical Trial and Consulting Inc. - Overview
Exhibit 128: CTI Clinical Trial and Consulting Inc. - Product / Service
Exhibit 129: CTI Clinical Trial and Consulting Inc. - Key offerings
12.6 Ergomed Plc
Exhibit 130: Ergomed Plc - Overview
Exhibit 131: Ergomed Plc - Business segments
Exhibit 132: Ergomed Plc - Key news
Exhibit 133: Ergomed Plc - Key offerings
Exhibit 134: Ergomed Plc - Segment focus
12.7 Eurofins Scientific SE
Exhibit 135: Eurofins Scientific SE - Overview
Exhibit 136: Eurofins Scientific SE - Business segments
Exhibit 137: Eurofins Scientific SE - Key news
Exhibit 138: Eurofins Scientific SE - Key offerings
Exhibit 139: Eurofins Scientific SE - Segment focus
12.8 ICON plc
Exhibit 140: ICON plc - Overview
Exhibit 141: ICON plc - Product / Service
Exhibit 142: ICON plc - Key offerings
12.9 IQVIA Holdings Inc.
Exhibit 143: IQVIA Holdings Inc. - Overview
Exhibit 144: IQVIA Holdings Inc. - Business segments
Exhibit 145: IQVIA Holdings Inc. - Key news
Exhibit 146: IQVIA Holdings Inc. - Key offerings
Exhibit 147: IQVIA Holdings Inc. - Segment focus
12.10 Laboratory Corp. of America Holdings
Exhibit 148: Laboratory Corp. of America Holdings - Overview
Exhibit 149: Laboratory Corp. of America Holdings - Business segments
Exhibit 150: Laboratory Corp. of America Holdings - Key news
Exhibit 151: Laboratory Corp. of America Holdings - Key offerings
Exhibit 152: Laboratory Corp. of America Holdings - Segment focus
12.11 Medpace Holdings Inc.
Exhibit 153: Medpace Holdings Inc. - Overview
Exhibit 154: Medpace Holdings Inc. - Product / Service
Exhibit 155: Medpace Holdings Inc. - Key offerings
12.12 Novotech Health Holdings
Exhibit 156: Novotech Health Holdings - Overview
Exhibit 157: Novotech Health Holdings - Product / Service
Exhibit 158: Novotech Health Holdings - Key offerings
12.13 Parexel International Corp.
Exhibit 159: Parexel International Corp. - Overview
Exhibit 160: Parexel International Corp. - Product / Service
Exhibit 161: Parexel International Corp. - Key news
Exhibit 162: Parexel International Corp. - Key offerings
12.14 PSI CRO AG
Exhibit 163: PSI CRO AG - Overview
Exhibit 164: PSI CRO AG - Product / Service
Exhibit 165: PSI CRO AG - Key offerings
12.15 Syneos Health Inc.
Exhibit 166: Syneos Health Inc. - Overview
Exhibit 167: Syneos Health Inc. - Business segments
Exhibit 168: Syneos Health Inc. - Key offerings
Exhibit 169: Syneos Health Inc. - Segment focus
12.16 Thermo Fisher Scientific Inc.
Exhibit 170: Thermo Fisher Scientific Inc. - Overview
Exhibit 171: Thermo Fisher Scientific Inc. - Business segments
Exhibit 172: Thermo Fisher Scientific Inc. - Key news
Exhibit 173: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 174: Thermo Fisher Scientific Inc. - Segment focus
12.17 WuXi AppTec Co. Ltd.
Exhibit 175: WuXi AppTec Co. Ltd. - Overview
Exhibit 176: WuXi AppTec Co. Ltd. - Business segments
Exhibit 177: WuXi AppTec Co. Ltd. - Key offerings
Exhibit 178: WuXi AppTec Co. Ltd. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 179: Inclusions checklist
Exhibit 180: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 181: Currency conversion rates for US$
13.4 Research methodology
Exhibit 182: Research methodology
Exhibit 183: Validation techniques employed for market sizing
Exhibit 184: Information sources
13.5 List of abbreviations
Exhibit 185: List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global contract research organization (cro) market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Application - Market share 2022-2027 (%)
Exhibits31: Data Table on Application - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Clinical research - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Clinical research - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Clinical research - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Clinical research - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Early phase development - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Early phase development - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Early phase development - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Early phase development - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Laboratory - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Laboratory - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Laboratory - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Laboratory - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Regulatory consulting - Market size and forecast 2022-2027 ($ billion)
Exhibits47: Data Table on Regulatory consulting - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Chart on Regulatory consulting - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Regulatory consulting - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Application ($ billion)
Exhibits51: Data Table on Market opportunity by Application ($ billion)
Exhibits52: Chart on End-user - Market share 2022-2027 (%)
Exhibits53: Data Table on End-user - Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by End-user
Exhibits55: Data Table on Comparison by End-user
Exhibits56: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ billion)
Exhibits57: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ billion)
Exhibits58: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Medical device companies - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Medical device companies - Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Medical device companies - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Medical device companies - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Academic institutes - Market size and forecast 2022-2027 ($ billion)
Exhibits65: Data Table on Academic institutes - Market size and forecast 2022-2027 ($ billion)
Exhibits66: Chart on Academic institutes - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Academic institutes - Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by End-user ($ billion)
Exhibits69: Data Table on Market opportunity by End-user ($ billion)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits108: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits109: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ billion)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: BioAgile Therapeutics Pvt. Ltd - Overview
Exhibits120: BioAgile Therapeutics Pvt. Ltd - Product / Service
Exhibits121: BioAgile Therapeutics Pvt. Ltd - Key offerings
Exhibits122: Charles River Laboratories International Inc. - Overview
Exhibits123: Charles River Laboratories International Inc. - Business segments
Exhibits124: Charles River Laboratories International Inc. - Key news
Exhibits125: Charles River Laboratories International Inc. - Key offerings
Exhibits126: Charles River Laboratories International Inc. - Segment focus
Exhibits127: CTI Clinical Trial and Consulting Inc. - Overview
Exhibits128: CTI Clinical Trial and Consulting Inc. - Product / Service
Exhibits129: CTI Clinical Trial and Consulting Inc. - Key offerings
Exhibits130: Ergomed Plc - Overview
Exhibits131: Ergomed Plc - Business segments
Exhibits132: Ergomed Plc - Key news
Exhibits133: Ergomed Plc - Key offerings
Exhibits134: Ergomed Plc - Segment focus
Exhibits135: Eurofins Scientific SE - Overview
Exhibits136: Eurofins Scientific SE - Business segments
Exhibits137: Eurofins Scientific SE - Key news
Exhibits138: Eurofins Scientific SE - Key offerings
Exhibits139: Eurofins Scientific SE - Segment focus
Exhibits140: ICON plc - Overview
Exhibits141: ICON plc - Product / Service
Exhibits142: ICON plc - Key offerings
Exhibits143: IQVIA Holdings Inc. - Overview
Exhibits144: IQVIA Holdings Inc. - Business segments
Exhibits145: IQVIA Holdings Inc. - Key news
Exhibits146: IQVIA Holdings Inc. - Key offerings
Exhibits147: IQVIA Holdings Inc. - Segment focus
Exhibits148: Laboratory Corp. of America Holdings - Overview
Exhibits149: Laboratory Corp. of America Holdings - Business segments
Exhibits150: Laboratory Corp. of America Holdings - Key news
Exhibits151: Laboratory Corp. of America Holdings - Key offerings
Exhibits152: Laboratory Corp. of America Holdings - Segment focus
Exhibits153: Medpace Holdings Inc. - Overview
Exhibits154: Medpace Holdings Inc. - Product / Service
Exhibits155: Medpace Holdings Inc. - Key offerings
Exhibits156: Novotech Health Holdings - Overview
Exhibits157: Novotech Health Holdings - Product / Service
Exhibits158: Novotech Health Holdings - Key offerings
Exhibits159: Parexel International Corp. - Overview
Exhibits160: Parexel International Corp. - Product / Service
Exhibits161: Parexel International Corp. - Key news
Exhibits162: Parexel International Corp. - Key offerings
Exhibits163: PSI CRO AG - Overview
Exhibits164: PSI CRO AG - Product / Service
Exhibits165: PSI CRO AG - Key offerings
Exhibits166: Syneos Health Inc. - Overview
Exhibits167: Syneos Health Inc. - Business segments
Exhibits168: Syneos Health Inc. - Key offerings
Exhibits169: Syneos Health Inc. - Segment focus
Exhibits170: Thermo Fisher Scientific Inc. - Overview
Exhibits171: Thermo Fisher Scientific Inc. - Business segments
Exhibits172: Thermo Fisher Scientific Inc. - Key news
Exhibits173: Thermo Fisher Scientific Inc. - Key offerings
Exhibits174: Thermo Fisher Scientific Inc. - Segment focus
Exhibits175: WuXi AppTec Co. Ltd. - Overview
Exhibits176: WuXi AppTec Co. Ltd. - Business segments
Exhibits177: WuXi AppTec Co. Ltd. - Key offerings
Exhibits178: WuXi AppTec Co. Ltd. - Segment focus
Exhibits179: Inclusions checklist
Exhibits180: Exclusions checklist
Exhibits181: Currency conversion rates for US$
Exhibits182: Research methodology
Exhibits183: Validation techniques employed for market sizing
Exhibits184: Information sources
Exhibits185: List of abbreviations
